November 9, 2011
The Pharmaceutical Affairs and Food Sanitation Council’s (PAFSC) First Committee on New Drugs approved a two-year extension of the reexamination period for Dainippon Sumitomo Pharma’s antipsychotic agent Lonasen Tablets 2 mg, 4 mg, and 8 mg, and Powder 2% (blonanserin)...read more